Anti-tumor activity of propofol: A focus on microRNAs.
MicroRNAs are endogenous, short, non-coding RNAs with the length as low as 20 to 25 nucleotides. These RNAs are able to negatively affect the gene expression at post-transcriptional level. It has been demonstrated that microRNAs play a significant role in cell proliferation, cell migration, cell death, cell differentiation, infection, immune response and metabolism. Besides, the dysfunction of microRNAs has been observed in a variety of cancers. So, modulation of microRNAs is of interest in treatment of disorders. The aim of the current review is to investigate the modulatory effect of propofol on microRNAs in cancer therapy. This review was performed at PubMed, SCOPUS and Web of Science data-bases using keywords "propofol', "microRNA", "cancer therapy", "propofol + microRNA" and "propofol + miR". It was found that propofol dually down-regulates/upregulates microRNAs to exert its anti-tumor activity. In terms of oncogenesis microRNAs, propofol exert inhibitory effect, while propofol significantly enhances the expression of oncosuppressor microRNAs. It seems that propofol is a potential modulator of microRNAs and this capability can be used in treatment of various cancers.